Paper
24 March 2023 Antiviral drugs against influenza viruses: oseltamivir and baloxavir
Shiyun Liang
Author Affiliations +
Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 1261161 (2023) https://doi.org/10.1117/12.2669580
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom
Abstract
Influenza, a recurring seasonal disease, causes over 5 million of illnesses annually worldwide and threatens the health of susceptible groups, including elderly people and children. Although several effective drugs such as neuraminidase inhibitors against influenza viruses have been marketed, the rapid evolution of new variants every flu season and the occurrence of resistant subtypes present a challenge to the prevention and treatment of influenza. This review chooses two representative anti-influenza drugs, oseltamivir (Tamiflu) and baloxavir (Xofluza), elucidating their origin, mode of action, chemical synthesis, and a brief comparison between them is made. Both of the drugs highlight the importance of structure-based design in pharmacy, providing insights in development of a new drug. Other strategies against influenza, including vaccination, are also discussed.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shiyun Liang "Antiviral drugs against influenza viruses: oseltamivir and baloxavir", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 1261161 (24 March 2023); https://doi.org/10.1117/12.2669580
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Viruses

Proteins

Polymers

Design and modelling

Ions

Resistance

Manganese

Back to Top